Crossover Trial of AD109 in Obstructive Sleep Apnea
Condition: Obstructive Sleep Apnea Interventions: Drug: AD109; Drug: Atomoxetine; Drug: R-oxybutynin; Drug: Placebo Sponsor: Apnimed Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials